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Browning of human adipocytes requires
KLF11 and reprogramming of PPARg
superenhancers
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Long-term exposure to peroxisome proliferator-activated receptor g (PPARg) agonists such as rosiglitazone
induces browning of rodent and human adipocytes; however, the transcriptional mechanisms governing this
phenotypic switch in adipocytes are largely unknown. Here we show that rosiglitazone-induced browning of
human adipocytes activates a comprehensive gene program that leads to increased mitochondrial oxidative
capacity. Once induced, this gene program and oxidative capacity are maintained independently of rosiglitazone,
suggesting that additional browning factors are activated. Browning triggers reprogramming of PPARg binding,
leading to the formation of PPARg ‘‘superenhancers’’ that are selective for brown-in-white (brite) adipocytes.
These are highly associated with key brite-selective genes. Based on such an association, we identified an
evolutionarily conserved metabolic regulator, Kruppel-like factor 11 (KLF11), as a novel browning transcription
factor in human adipocytes that is required for rosiglitazone-induced browning, including the increase in
mitochondrial oxidative capacity. KLF11 is directly induced by PPARg and appears to cooperate with PPARg in
a feed-forward manner to activate and maintain the brite-selective gene program.
[Keywords: browning of human adipocytes; KLF11; PPARg; superenhancer; genomic reprogramming; rosiglitazone]
Supplemental material is available for this article.
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Obesity has reached pandemic proportions and poses
a tremendous threat to human health. Current strategies
for therapy aim at restoring the obesity-causing energy
imbalance in humans by either decreasing energy uptake
or increasing energy expenditure. In this regard, promis-
ing targets for treatment of human obesity are brown and
‘‘beige/brite (brown in white)’’ adipose tissues (Harms and
Seale 2013), which have been shown to be metabolically
significant tissues in both rodents and adult humans
(Kopecky et al. 1995; Guerra et al. 1998; Feldmann et al.
2009; Seale et al. 2011; Ouellet et al. 2012; Yoneshiro et al.
2013). The expression of uncoupling protein 1 (UCP1) in
residing adipocytes allows uncoupling of mitochondria and
thereby conversion of fatty acids and glucose into heat.
Traditionally, UCP1-positive adipocytes in rodents have
been distinguished into classical brown adipocytes from
brown adipose tissue (BAT) and brite (Petrovic et al.
2010)/beige (Ishibashi and Seale 2010) (hereafter termed
brite) adipocytes fromwhite adipose tissue (WAT) (Harms
and Seale 2013). Recently, several studies demonstrated that
human adults have separate depots of brown(-like) adipo-
cytes interspersed among white adipocytes in the supra-
clavicular, para-aortic, and suprarenal fat depots (Cypess
et al. 2009; van Marken Lichtenbelt et al. 2009; Virtanen
et al. 2009). It is currently unclear whether these human
brown(-like) adipocytes more resemble the inducible brite
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adipocytes found in the WAT of mice rather than the
classical brown adipocytes from BAT (Sharp et al. 2012;
Wu et al. 2012; Cypess et al. 2013; Lidell et al. 2013).
Nevertheless, there is a growing clinical interest in un-
derstanding how brite adipocytes develop, especially since
the emergence of brite adipocytes inWATis associatedwith
protection against obesity and metabolic dysfunctions in
several rodent models (Seale et al. 2011; Cohen et al. 2014).
The appearance of brite adipocytes can be induced by
several different thermogenic stimuli, including cold and
b-adrenergic stimulation (Cousin et al. 1992;Himms-Hagen
et al. 1994). In addition, long-term exposure to synthetic
ligands of peroxisome proliferator-activated receptor g
(PPARg), a key activator of both white and brown
adipocyte differentiation (Lefterova et al. 2014), has been
shown to promote the formation of functional brite
adipocytes in cultures of rodent white adipocytes and in
WAT (Fukui et al. 2000; Wilson-Fritch et al. 2004;
Petrovic et al. 2010). Interestingly, studies using human
preadipocytes, including human multipotent adipose-
derived stem (hMADS) cells, indicate that the ability of
PPARg agonists to induce functional brite cells is con-
served in humans (Digby et al. 1998; Elabd et al. 2009).
Mechanistically, it has been suggested that PPARg ligands
induce brown/brite-selective genes by directly activating
PPARg at nearby regulatory regions (Sears et al. 1996).
However, browning is not immediately induced (Petrovic
et al. 2010; Haakonsson et al. 2013), indicating that activa-
tion and stabilization of the brite adipocyte gene program by
rosiglitazone requires activation of additional indirect ef-
fectors that may help reprogram the chromatin template.
Candidates for such rosiglitazone-induced effectors have
been identified in rodents and include the cofactors PGC-1a
(Hondares et al. 2006) and PRDM16 (Ohno et al. 2012). At
present, however, these rosiglitazone-induced effectors re-
main elusive. Furthermore, little is known about the
molecular mechanisms underlying browning of human
adipocytes, and genome-wide insight into the transcrip-
tional reprogramming of the genome and the transcriptional
networks involved is completely lacking.
In this study, we characterized for the first time the
transcriptional processes underlying browning of human
adipocytes using a genome-wide approach. We show that
this is associated with reprogramming of PPARg binding
to form brite-selective PPARg superenhancers that ap-
pear to play a key role in activation of brite-selective
genes. We identify the Kruppel-like factor 11 (KLF11)
gene based on its association with a brite-selective PPARg
superenhancer and show that KLF11 is a novel browning
factor directly induced by rosiglitazone and required for
the activation of brite-selective genes by rosiglitazone.
Results
Browning of human adipocytes stimulates
a comprehensive stable gene program linked
to mitochondrial oxidative capacity
To explore the transcriptional mechanisms underlying
the browning process of human adipocytes, we exposed
mature white hMADS adipocytes to the PPARg ligand,
rosiglitazone, for 3 d (i.e., days 13–16 of differentiation)
(Fig. 1A). As previously shown, rosiglitazone induces the
expression of well-established brown/brite adipocyte
markers (Elabd et al. 2009; Pisani et al. 2011) such as
UCP1, CIDEA, ELOVL3, and DIO2, whereas expression
of the common adipocyte markers PLIN1/2, SCD, and
FASN as well as the degree of fat synthesis and lipid
accumulation are comparable in white and brite adipo-
cytes (Fig. 1B–D; Supplemental Fig. S1A–C). Interestingly,
once induced, the expression of brite-selective marker
genes is maintained from day 16 to day 19 and further
until day 23 independently of continued rosiglitazone
administration (Fig. 1C,D), indicating that a stable brite
adipocyte gene program has been switched on. Establish-
ment of a full brite phenotype requires long-term exposure
to rosiglitazone, since a short 2-h pulse of rosiglitazone in
mature hMADS adipocytes at day 13 is insufficient for full
activation ofUCP1 transcription (Supplemental Fig. S1D),
suggesting that the induction of additional factors are
needed to effectively activate a brite gene program in
hMADS adipocytes.
To examine the global transcriptional changes associ-
ated with browning of white adipocytes, we performed
RNA sequencing (RNA-seq) in hMADS preadipocytes as
well as in mature white and brite hMADS adipocytes
deprived of rosiglitazone. Principal component analysis
based on gene expression profiles showed that preadipo-
cytes and white and brite hMADS adipocytes separate
into three clusters corresponding to distinct cell types
(Supplemental Fig. S2A). Comparison of white and brite
adipocytes identified a total of 2829 differentially expressed
genes (false discovery rate [FDR] < 0.05), of which 1691
are brite-selective and 1138 are white-selective (Fig. 1E;
Supplemental Fig. S2B). Notably, several known white
and brown/brite marker genes are differentially expressed
between white and brite hMADS adipocytes (Fig. 1F).
The gene programs that are selective for brite adipocytes
are associated with increased mitochondrial function and
energy consumption (Supplemental Table S1; Supplemen-
tal Fig. S2C). Importantly, this leads to a significant in-
crease in basal,maximal, and uncoupled respiration in brite
compared with white adipocytes, which is maintained in
rosiglitazone-deprived brite adipocytes at day 19 (Fig. 1G).
In contrast, genes selectively expressed in white hMADS
adipocytes belong to pathways associated with amino acid
metabolism (Supplemental Table S1). Taken together,
these results demonstrate that distinct ‘‘stable’’ gene pro-
grams are active in white and brite hMADS adipocytes and
that the brite-selective gene program is associated with
functional properties of the brite adipocytes.
Cell type-selective PPARg binding correlates
with active chromatin signatures and cell type-selective
gene expression
To determine the degree of reprogramming of the chro-
matin template and identify putative active chromatin
regions (Crawford et al. 2006), we generated genome-wide
DNase I-hypersensitive (DHS) site profiles in white and
Loft et al.
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brite hMADS adipocytes. Notably, despite considerable
changes in gene expression during browning, the DHS
profiles overall were very similar in white and brite
adipocytes (Supplemental Fig. S3A,B), indicating that
the transcriptional changes during browning occur with-
out major changes in the chromatin landscape.
We and others have recently shown the existence of
robust fat depot-selective binding of PPARg linked to
depot-specific gene expression in mice (Siersbæk et al.
2012; Rajakumari et al. 2013), indicating that PPARg, in
addition to its role as a general activator of adipogenesis
in mice (Lefterova et al. 2008; Nielsen et al. 2008) and
humans (Mikkelsen et al. 2010; Schmidt et al. 2011; Soccio
et al. 2011), plays a prominent role in the induction of
genes characteristic of different adipocyte lineages. The fact
that browning is induced by the PPARg ligand rosiglitazone
indicates that PPARg is also a major driver of the genomic
reprogramming during browning. To investigate this, we
generated PPARg chromatin immunoprecipitation (ChIP)
sequencing (ChIP-seq) profiles in white and brite hMADS
adipocytes. From a total of 52,030 PPARg-binding sites, we
identified 4439 reprogrammed PPARg-binding sites with
differential PPARg-binding intensity (FDR < 0.1) in white
and brite adipocytes (2228 white-selective and 2211 brite-
selective) (Fig. 2A). Furthermore, we defined a group of 2385
constant sites that show comparable PPARg-binding sig-
nal in these two cell populations. Notably, levels of PPARg
protein are comparable in brite and white adipocytes
Figure 1. Browning of hMADS adipocytes
induces a stable gene program linked to
enhanced mitochondrial oxidative capacity.
(A) Schematic overview of hMADS differ-
entiation. hMADS cells were induced to
differentiate using an adipogenic cocktail.
Mature white adipocytes were treated with
DMSO to remain white adipocytes or with
rosiglitazone (+rosi) to become brite adipo-
cytes. Rosiglitazone was omitted from the
differentiation medium from day 16. (B)
White and brite hMADS adipocyte cultures
were fixed with formaldehyde and stained
with oil-red-O. Representatives of phase-
contrast micrographs are displayed. (C,D)
Expression of UCP1 (C) and brown/brite
adipocyte markers (D) in white (W, light
blue) and brite (B, orange) hMADS adipo-
cytes at the indicated days. Error bars repre-
sent SD (n = 3). (***) P < 0.001; (**) P < 0.005;
(*) P < 0.05; (NS) not significant (P > 0.05),
as indicated. (E) Heat map showing log2 fold
change for white-selective (1138 genes) and
brite-selective (1691 genes) (FDR < 0.05)
genes as well as a group of constitutively
expressed genes (977 genes with FDR > 0.9
and log2 fold change < 2.5%) from three
independent biological replicates in white
and brite hMADS adipocytes at day 19. (F)
Mean expression values (as normalized exon
reads per kilobase) from three RNA-seq data
replicates for a subset of previously reported
brite- and white-selective genes as well as
general adipocyte markers. (G) Oxygen con-
sumption rate (OCR) measured in white
(W, light blue) and brite (B, orange) hMADS
adipocytes at days 16 and 19. (Left) The
arrows indicate time of addition for oligo-
mycin, FCCP, and rotenone/antimycin A.
(Right) Uncoupled, maximal, and basal res-
piration in white and brite hMADS adipo-
cytes. Error bars represent SEM (n = 3). (*) P <
0.05 as indicated.
KLF11 regulates browning of human adipocytes
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(Supplemental Fig. S4A). The fact that <10% of the total
number of PPARg-binding sites is reprogrammed indi-
cates that most of the transcriptional functions of PPARg
are maintained in the brite adipocytes. Nevertheless,
reprogrammed PPARg-binding sites are high-intensity
sites compared with the group of constant sites and thus
are likely to represent key regulatory elements (Supple-
mental Fig. S4B). De novo motif analysis did not show
major differences in motif enrichment between the dif-
ferent groups of sites. The PPAR response element is the
top-scoring motif in all three groups, whereas the NF1
half-site is enriched inwhite-selective and constant PPARg-
binding sites, and the C/EBP motif is enriched in brite-
selective and constant PPARg-binding sites (Supplemental
Fig. S4C). To investigate the activity of these reprogrammed
PPARg-binding sites, we evaluated the DHS sequencing
(DHS-seq) profiles as well as ChIP-seq profiles of the
subunit 1 of theMediator complex (MED1), the coactivator
CREB-binding protein (CBP), and the histone mark
H3K27ac, all of which are known to be marks of active
regulatory regions (Crawford et al. 2006; Heintzman et al.
2009; Creyghton et al. 2010; Kagey et al. 2010; Rada-Iglesias
et al. 2011). Interestingly, brite-selective PPARg-binding
sites are found in regions that appear to be most active in
brite adipocytes (Fig. 2B; Supplemental Fig. S4D). Simi-
larly, white-selective PPARg-binding sites are found in
regions with elevated activity in white adipocytes,
whereas constant PPARg-binding sites display no major
differences in activating chromatin marks between white
and brite adipocytes. These results demonstrate that
although no major overall changes occur in the chroma-
tin template during browning, the reprogrammed PPARg-
binding sites are associated with local remodeling of the
chromatin and signatures of increased transcriptional
Figure 2. PPARg binding is reprogrammed during browning of hMADS adipocytes. (A) Scatter plot showing PPARg signal (as edgeR-
normalized tag count in a 400-base-pair [bp] window) in PPARg-binding sites in white and brite hMADS adipocytes at day 19.
Reprogrammed (FDR < 0.1) white-selective (blue, 2228 peaks) and brite-selective (red, 2211 peaks) PPARg-binding sites are shown. A
group of constant PPARg-binding sites (green, 2385 peaks) was defined as those having a FDR > 0.95 and a fold change < 2.5%. The
remaining PPARg-binding sites are black. (B) Heat map showing the log2 fold change in PPARg, DHS, CBP, MED1, and H3K27ac signal
at reprogrammed PPARg-binding sites in brite compared with white hMADS adipocytes. PPARg, DHS, CBP, and MED1 signals were
counted in a 400-bp window, and H3K27ac signal was counted in a 2-kb window around the PPARg peak center. (C) Enrichment of the
brite-selective (red), white-selective (blue), and constant (green) PPARg-binding sites in the vicinity of top brite-selective (603 genes) or
white-selective (292 genes) genes. Enrichment was determined as the number of binding sites per gene within different distances from
the transcription start site (TSS; 10–100 kb) of top regulated genes relative to the number of binding sites per gene of constitutively
expressed genes, as defined in Figure 1E. (D) ChIP-seq profiles of PPARg, MED1, H3K27ac, and input control at the ACSL5 and UCP1
loci in white and brite hMADS adipocytes. The arrows indicate brite-selective PPARg-binding sites. (E) Bar plot showing the mean tag
count in brite-selective PPARg-binding sites (indicated with arrows in D) for duplicate MED1 (400-bp window) and H3K27ac (2-kb
window) ChIP-seq libraries in white (light blue) and brite (orange) hMADS adipocytes. The input signal in white (white) and brite (black)
hMADS adipocytes in the given window is plotted as a control. Error bars represent SEM (n = 2).
Loft et al.
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activity. The role of PPARg as a major determinant of
enhancer activity is supported by the fact that PPARg
binding positively correlates with activating enhancer
signatures at all identified PPARg-binding sites (Supple-
mental Fig. S5A). Interestingly, the cell type-selective
PPARg-binding events are highly enriched near cell type-
selective genes (Fig. 2C), including brite-selective genes such
as UCP1 and ACSL5 (Fig. 2D,E; Supplemental Fig. S5B).
Thus, these genome-wide analyses extend previous results
based on single genes and indicate that PPARg is a critical
direct activator of the brite-selective gene program.
Brite-selective PPARg superenhancers are highly
enriched near brite-selective genes
It has recently been shown that superenhancers (i.e.,
clusters of enhancers) constitute particularly powerful
regulatory nodes controlling expression of genes defining
cell identity (Loven et al. 2013; Whyte et al. 2013). To
identify such key regulatory regions in hMADS adipo-
cytes and determine whether they change during brown-
ing, wemerged all identified PPARg-binding sites in close
proximity (within 12.5 kb from each other) and ranked
them according to the intensity of their associated MED1
signal. Using this approach, we identified 1106 PPARg
superenhancers in brite adipocytes that have elevated
levels of MED1 signal compared with regular PPARg-
binding regions in two independent biological replicates
(Fig. 3A). Compared with regular PPARg enhancers, the
constituent PPARg-binding regions within PPARg super-
enhancers are enriched in MED1, H3K27ac, DHS, and
CBP signal (Fig. 3B; Supplemental Fig. S6A), indicating
that the constituent PPARg enhancers in superenhancers
are significantly more active than regular PPARg en-
hancers. Furthermore, the PPARg signal intensity is higher
in the PPARg superenhancer constituents compared with
regular PPARg-binding regions, indicating that PPARg
plays an active role in the formation of superenhancers.
To identify key cell type-selective regulatory regions,
we examined PPARg superenhancers with differential
MED1 signal in white and brite adipocytes. From a total
of 1212 superenhancers identified in white and/or brite
adipocytes, we identified 304 white-selective and 324
brite-selective (FDR < 0.01) as well as 148 constant
PPARg superenhancers (Fig. 3C). Interestingly, brite- and
white-selective PPARg-binding sites are highly enriched
in brite- and white-selective superenhancers, respectively
(Fig. 3D). Furthermore, PPARg-binding intensity is signifi-
cantly higher at brite-selective sites than nonreprogrammed
PPARg sites within brite-selective superenhancers (Sup-
plemental Fig. S6B). This indicates that superenhancers
with cell type-selective activity arise as a consequence of
PPARg reprogramming during the browning process. This
is further supported by the fact that within these super-
enhancers, the increase in MED1 and H3K27ac signal
in brite compared with white adipocytes is more pro-
nounced at enhancer constituents where there is brite-
selective binding of PPARg compared with enhancer
constituents where PPARg binding is independent of cell
type (Supplemental Fig. S6C).
Annotation of PPARg superenhancers to the nearest
genes showed that cell type-selective PPARg superen-
hancers are highly enriched in the vicinity of cell type-
selective genes and that the enrichment is much higher
than for regular cell type-selective PPARg enhancers
(Fig. 3E). Notably, brite-selective genes associated with
brite-selective superenhancers are induced significantly
more during browning and are expressed at much higher
levels compared with brite-selective genes that do not
have a super-enhancer associated with them (Fig. 3F).
Furthermore, brite-selective genes associated with brite-
selective superenhancers belong to brite-selective metabolic
pathways, such as fatty acid degradation and b-oxidation
(Supplemental Fig. S7A). Several of these metabolic genes
are also marked by brite-selective PPARg superenhancers
defined by H3K27ac signal (Supplemental Fig. S7B).
Examples of prominent brite-selective genes associated
with brite-selective superenhancers are PDK4, ACSL5,
CIDEA, and DIO2, whereas common PPARg superen-
hancers are found near general adipocyte genes such as
PLIN1/2 and SCD1 (Fig. 3G,H; Supplemental Fig. S7C–
G). Taken together, these data indicate that brite-selec-
tive PPARg superenhancers are crucial regulatory regions
for controlling key brite-selective genes.
Rosiglitazone treatment induces the superenhancer-
associated gene KLF11 in human adipocytes
and subcutaneous fat of human type 2 diabetic
(T2D) patients
Superenhancers have been reported to be associated with
genes that define cellular function (Whyte et al. 2013). In
linewith this, we identified commonwhite and brite PPARg
superenhancers associated with key adipocyte regulatory
factors, including C/EBPb, PPARg, and STAT5A. To search
for novel transcriptional mediators of the rosiglitazone-
induced browning of human adipocytes, we examined
the genes associated with a brite-selective PPARg super-
enhancer (see Supplemental Fig. S7B for examples). In-
terestingly, we observed a prominent brite-selective PPARg
superenhancer (as determined by both MED1 and H3K27ac
ranking) near the gene encoding KLF11 (Fig. 4A; Supple-
mental Fig. S7B,E). KLF11 (also called MODY7) is
a well-known regulator of pancreatic b-cell function,
and human genetic variants have been associated with
dysfunctional b cells and diabetes (Neve et al. 2005;
Bonnefond et al. 2011). In nonadipocyte cell lineages,
KLF11 regulates several metabolic gene networks and
acts as both an activator and a repressor of transcription
(Fernandez-Zapico et al. 2009; Seo et al. 2012; Lomberk
et al. 2013). Moreover, it was recently shown that
KLF11 can activate UCP1 expression in mouse bone
marrow-derived stem cells (Yamamoto et al. 2010), sug-
gesting that KLF11 could be a browning factor. However,
whether and how it functions as such in mice are unclear.
Furthermore, its role in human adipocytes remains totally
unknown.
Consistent with the association of KLF11 with a brite-
selective PPARg superenhancer, we found that KLF11 is
expressed at higher levels in brite compared with white
KLF11 regulates browning of human adipocytes
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adipocytes and that this level is maintained at least until
day 23 (Fig. 4B; Supplemental Fig. S8A,B). Furthermore,
we found compelling evidence that KLF11 is directly
activated by PPARg during browning of human adipo-
cytes. First, we showed that the expression of KLF11 in
brite adipocytes is dependent on PPARg (Fig. 4C; Sup-
plemental Fig. S8C). Second, treatment of mature brite
adipocytes with the selective PPARg antagonist
GW9662 leads to an acute reduction of KLF11 pre-
mRNA levels (Supplemental Fig. S8D). Third, KLF11
pre-mRNA levels are significantly induced only 2 h after
rosiglitazone treatment of mature hMADS adipocytes,
and this increased transcription is maintained inmature
brite adipocytes (Fig. 4D). Collectively, these results
indicate that KLF11 is a brite-selective factor directly
induced by PPARg in hMADS adipocytes, most likely as
a result of PPARg binding to clusters of binding sites in the
vicinity of the gene.
It has recently been demonstrated that cooling of white
and brite murine adipocytes activates a b-adrenergic-
independent thermogenic gene program (Ye et al. 2013).
Interestingly, brite (Supplemental Fig. S8E) but not white
hMADS adipocytes (data not shown) respond to 4 h of
cooling at 31°C by an increase in the expression ofUCP1
and a subset of other brite-selective genes, including
KLF11. Furthermore, b-adrenergic stimulation of brite
(Supplemental Fig. S8F) but not white hMADS adipocytes
(data not shown) leads to a modest increase in UCP1 and
KLF11. This demonstrates that although these thermo-
genic stimuli are insufficient for induction of browning
Figure 3. Brite-selective PPARg superen-
hancers are highly enriched near brite-selec-
tive genes. (A) All identified PPARg-binding
sites (52,030) within 12.5 kb of each other
were merged, resulting in 31,466 regions.
These PPARg regions in brite hMADS adipo-
cytes were ranked according to input-sub-
tracted signal of MED1. Regions with >200
reads (minus input signal) per 10 million total
reads in both MED1 replicates were defined
as superenhancers (green). All other regions
were denoted as regular PPARg-binding re-
gions (gray). (B) MED1 and PPARg (400-bp
window) as well as H3K27ac (2-kb window)
signal (as tag count per peak) in PPARg
constituents in regular PPARg-binding re-
gions (gray, 46,392 peaks) and PPARg super-
enhancers (green, 5638 peaks) in brite
hMADS adipocytes. (*) P < 2.2 1016 as in-
dicated, Wilcoxon rank-sum test. (C) MA plot
showing meanMED1 signal (as edgeR-normal-
ized tag count) versus the log2 fold change in
MED1 signal for a given PPARg superenhancer
(SE) in brite compared with white hMADS
adipocytes. PPARg superenhancers with sig-
nificantly (FDR < 0.01) elevated MED1 tag
counts in white (blue, 304 regions) and brite
(red, 324 regions) hMADS adipocytes are
shown. A group of constant PPARg super-
enhancers (green, 148 regions) was defined as
regions having an FDR > 0.6, and the rest of
the common PPARg superenhancers are shown
in black. (D) Fraction of white-selective (gray)
and brite-selective (black) PPARg-binding sites
in white-selective (blue), brite-selective (red),
and constant (green) PPARg superenhancers (SE).
Significance was determined by Fisher’s exact
test as indicated. (E) Enrichment of brite-selec-
tive (red), white-selective (blue), and constant
(green) PPARg superenhancers (solid line) or
regular binding regions (dotted line) near the top brite-selective and white-selective genes. Enrichment was determined as the number
of binding sites per gene within different distances from the TSS (10–100 kb) of the top regulated genes relative to the number of binding
sites per gene of constitutively expressed genes, as defined in Figure 1E. (F) Log2 fold change in the expression of brite compared with
white hMADS adipocytes (left) and normalized exon reads per kilobase in brite hMADS adipocytes (right) for brite-selective genes
associated (red) or not (gray) with brite-selective superenhancers. (G,H) ChIP-seq profiles of MED1, H3K27ac, PPARg, and input control
at the ACSL5 and PDK4 (G) and PLIN1 (H) loci in white (light blue) and brite (orange) hMADS adipocytes. The red and green lines
indicate the positions of brite-selective and common PPARg superenhancers, respectively.
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per se, they lead to further activation of KLF11 along
with the brite-selective gene program in brite hMADS
adipocytes.
Next, we examined whether rosiglitazone treatment of
human adults has any effect on KLF11 expression in sub-
cutaneous fat. For this purpose, we used a human cohort
consisting of 18 T2D patients treated with rosiglitazone
for 90 d (Tan et al. 2005). Interestingly, rosiglitazone
treatment leads to a statistically significant induction
of KLF11 expression in abdominal subcutaneous fat of
T2D subjects compared with placebo treatment (Fig. 4E).
UCP1 expression was below the detection limit in 16 out
of 18 placebo-treated individuals in this cohort; however,
upon 90 d of rosiglitazone treatment, UCP1 expression
became detectable in eight out of 18 T2D patients (Supple-
mental Fig. S8G), suggesting that some degree of brown-
ing occurs in the subcutaneous fat in response to
rosiglitazone. Taken together, this demonstrates that
KLF11 is a direct PPARg target gene that is induced by
rosiglitazone during in vitro as well as in vivo browning
of human adipocytes.
KLF11 specifically activates the brite adipocyte gene
program
We next addressed whether KLF11 plays an active role in
the regulation of the human brite adipocyte gene pro-
gram. Using two different lentiviral shRNA constructs,
we found that knockdown of KLF11 in mature hMADS
adipocytes significantly inhibits the induction of UCP1
upon rosiglitazone stimulation (Fig. 5A,B). In contrast,
knockdown of a white-selective factor, ZNF323, resulted
in a robust induction of UCP1 mRNA expression com-
pared with the scramble control (Supplemental Fig. S9A).
Consistent with the effect on UCP1 expression, we found
that a subset of functionally important brite-selective
genes is significantly repressed by KLF11 knockdown,
whereas a control group consisting of white and general
adipocyte marker genes is not (Fig. 5B). Importantly,
PPARg expression is comparable in control cells and cells
with knockdown of KLF11, demonstrating that the effect
on brite-selective gene expression is not mediated by
feedback regulation of PPARg (Fig. 5A,B). Interestingly,
the gene encoding FHL1 is also associated with a brite-
selective superenhancer (Supplemental Fig. S9B,C), and
we show that FHL1, similar to KLF11, is required for
browning (Supplemental Fig. S9D). This demonstrates
that brite-selective superenhancers can be used as a dis-
covery tool to identify key regulatory factors for the
browning process.
Investigation of the global effect of KLF11 on the brite-
selective gene program by RNA-seq (Supplemental Fig.
S10A) showed that a large fraction of brite-selective genes
(17.4%) is significantly repressed by KLF11 knockdown,
whereas a significantly lower fraction (4.3%) is induced.
Furthermore, only minor fractions of white-selective and
constitutively expressed genes are affected by KLF11
knockdown (Fig. 5C). These results indicate that KLF11
acts predominantly as an activator of the brite-selective
gene program. Notably, functional enrichment analysis
Figure 4. Rosiglitazone treatment induces the
superenhancer-associated gene KLF11 in vitro and
in vivo. (A) ChIP-seq profiles of MED1, H3K27ac,
PPARg, and input control at the KLF11 locus in
white (light blue) and brite (orange) hMADS adipo-
cytes. The red line indicates the position of the
brite-selective PPARg superenhancer. (B) Expression
of KLF11 mRNA (left) and KLF11 and UCP1 protein
(right) in white (light blue) and brite (orange)
hMADS adipocytes at day 19. (C) KLF11 mRNA
(left) and protein (right) expression at day 16 of
hMADS adipocyte differentiation with or without
knockdown of PPARg. hMADS adipocytes were
transduced with lentiviral vectors expressing either
scramble (black) or PPARg (white) shRNA at day 10
and subsequently treated with rosiglitazone from
day 13 to day 16 to induce browning. (D) KLF11 pre-
mRNA levels in hMADS adipocytes at day 13
treated for 2 h with DMSO (white) or rosiglitazone
(light orange) or differentiated to day 19 white (light
blue) and brite (orange) adipocytes. In B–D, error
bars represent SD (n = 3). (**) P < 0.005; (*) P < 0.05.
(E) Relative expression (left) and log2 fold change
(right) of KLF11 in human subcutaneous abdominal
WAT from a total of 18 subjects treated for 3 mo
with placebo and then 3 mo with rosiglitazone or
vice versa. mRNA expression was normalized to
control genes PPIA and PGK1. Details on the human
cohort were previously described (Tan et al. 2005).
Significance was determined using Wilcoxon matched
pairs signed-ranks test.
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revealed that the majority of genes repressed by KLF11
knockdown belong to brite-selective metabolic pathways
(Supplemental Table S1), such as fatty acidmetabolism and
oxidative phosphorylation (Fig. 5D). Importantly, the abil-
ity of rosiglitazone to induce a higher oxygen consumption
rate (OCR; i.e., basal, maximal, and uncoupled respiration)
and fatty acid oxidation capacity is completely abolished
by KLF11 knockdown (Fig. 5E; Supplemental Fig. S10B).
Thus, KLF11 is required for the ability of rosiglitazone to
induce a brite phenotype in hMADS adipocytes.
To investigate whether KLF11 is capable of further
activating brite-selective genes, we modestly overex-
pressed KLF11 in brite hMADS adipocytes using an
adenoviral vector (Fig. 5F) and evaluated the effects on
the subset of genes examined in Figure 5, A and B.
Interestingly, overexpression of KLF11 causes a signifi-
cant increase in mRNA levels of the majority of these
brite-selective genes (Fig. 5F; Supplemental Fig. S10C),
whereas there is little effect on general and white adipo-
cyte marker genes. Collectively, these results show that
KLF11 plays an important and rate-limiting role in the
induction of the brite-selective gene program and an
oxidative phenotype in hMADS adipocytes.
KLF11 induces brite-selective genes by activating
nearby regulatory regions
To address the question of whether KLF11 directly acti-
vates brite-selective genes, we investigated whether KLF11
Figure 5. KLF11 specifically activates the
brite adipocyte gene program. (A) KLF11
mRNA (top) and KLF11, UCP1, and PPARg
protein (bottom) expression in day 16 hMADS
adipocytes transduced with lentivirus express-
ing either scramble shRNA (black) or one of
two different KLF11 shRNAs (red) at day 10.
hMADS adipocytes were subsequently treated
with rosiglitazone from day 13 to day 16. Error
bars represent SD (n = 3). (***) P < 0.001
compared with scramble control. (B) Expres-
sion levels of brite (top) and white and general
(bottom) adipocyte markers in hMADS adi-
pocytes transduced with lentivirus and stim-
ulated with rosiglitazone as described in A.
Error bars represent SD (n = 3). (#) P-value <
0.02 for both lentiviral constructs compared
with scramble control. (C) Fraction of the top
brite- and white-selective genes that are sig-
nificantly (FDR < 0.1) induced (red) or repressed
(blue) by KLF11 knockdown. Significance was
determined by Fisher’s exact test as indicated.
(D) Genes either repressed or induced by KLF11
knockdown were subjected to functional en-
richment analyses. Enrichment was tested for
a subset of brite and white adipocyte-selective
metabolic pathways as determined in Supple-
mental Table S1. P-values are illustrated in
the heat map. (E) OCR in hMADS adipocytes
transduced with lentivirus expressing either
scramble shRNA (black) or two different KLF11
shRNA (red) at day 10 and subsequently treated
with DMSO or rosiglitazone from day 13 to day
16. (Left) The arrows indicate time of addition
for oligomycin, FCCP, and rotenone/antimycin
A. (Right) Uncoupled, maximal, and basal
respiration in scramble and KLF11 knock-
down cells. Error bars represent SEM (n = 3).
(*) P < 0.05 as indicated. (F) Rosiglitazone-
treated hMADS adipocytes (day 15) were
subjected to KLF11 adenovirus (AdKLF11) or
empty adenoviral control (AdEV), and expression
was evaluated 24 h after transduction. (Top)
Overexpression of KLF11 was evaluated by
Western blot. (Bottom) Log2 fold change in
gene expression in AdKLF11-treated cells
compared with AdEV-treated cells for a subset of brite-selective genes as well as a control group of genes (as defined in A,B). The
red lines represent the medians of the data sets. Significance was determined by Student’s t-test.
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occupies sites in the vicinity of brite-selective genes
regulated by KLF11. Antibody specificity was validated
by KLF11 knockdown followed by ChIP-qPCR at selected
sites (Supplemental Fig. S11A). Interestingly, we detected
significant KLF11 binding in close proximity to several
brite-selective genes, including UCP1, PDK4, FABP3, and
DIO2, in brite hMADS adipocytes (Fig. 6A). Genome-wide
binding profiling of KLF11 in white and brite hMADS
adipocytes identified a total of 38,391 binding sites.
As reported for KLF1 (Pilon et al. 2011), KLF11
binding is most prominent at gene promoter regions,
although robust binding to distal regions can also
be detected (Fig. 6B). Importantly, however, there is a highly
significant enrichment of a motif resembling the SP1/KLF
motif in all of these groups, suggesting that KLF11 binds
directly to both promoter and more distal sites (Supple-
mental Fig. S11B). Interestingly, KLF11 binding at PPARg
enhancer constituents within superenhancers in brite
adipocytes is elevated compared with that at regular
PPARg enhancers (Fig. 6C), indicating that KLF11 is
particularly associated with PPARg in superenhancers.
Coimmunoprecipitation of KLF11 and PPARg in brite
hMADS adipocytes showed that they are able to interact,
indicating potential direct cooperativety between these
Figure 6. KLF11 is a direct activator of brite-
selective genes. (A) KLF11 binding to target
sites in the vicinity of a subset of brite-
selective genes in brite hMADS adipocytes
as determined by ChIP-qPCR. Binding of
KLF11 (black) and IgG (white) to selected
sites (UCP1 7 kb, FABP3 8.5 kb, ACSL5
+7.3 kb, PDK4 promoter, APOL6 promoter,
DIO2 promoter, ELOVL3 17.9 kb, HADHB
promoter, and IDH3A promoter) expressed
as the percentage of recovery compared with
the input sample. A negative control region
(without any binding of KLF11) is included.
Error bars represent SEM (n = 3). (*) P-value <
0.05 compared with negative control. (B)
KLF11 signal (as tag count per peak in
a 400-bp window) in KLF11-binding sites in
promoter (white, 16,390 sites within 2 kb of
the TSS), near distal (light gray, 4529 sites
from 2 kb to 10 kb away from the TSS), and
far distal (dark gray, 9680 sites from 10 kb to
50 kb away from the TSS) regions in brite
hMADS adipocytes. Input signal in all KLF11-
binding sites is shown as a control (black).
Significance was determined by Wilcoxon
rank-sum test. (C) KLF11 signal (as tag count
per peak in a 400-bp window) in PPARg
constituents (left) and the fraction of PPARg
constituents with KLF11 binding (right) in
regular PPARg-binding regions (gray, 46,392
peaks) and PPARg superenhancers (green,
5638 peaks) in brite hMADS adipocytes. (*)
P < 2.2 3 1016 as indicated, Wilcoxon rank-
sum test (left panel) and Pearson’s x2 test
(right panel). (D) Percentage of the top brite-
and white-selective genes as well as consti-
tutively expressed genes (as defined in Fig.
1E), that have a KLF11-activated (red, 1179
sites) or KLF11-repressed (blue, 489 sites)
binding site (BS) within 50 kb of the TSS. (E) Enrichment of KLF11-activated (red), KLF11-repressed (blue), or KLF11-unaffected (green,
1076 sites) binding sites (BS) near the top brite-selective genes (left) and the top brite-selective genes significantly repressed by KLF11
knockdown (right). Enrichment was determined as the number of binding sites per gene within different distances from the TSS (0–100
kb) of regulated genes relative to the number of binding sites per gene of constitutively expressed genes as defined in Figure 1E. (F) ChIP-
seq binding profiles of KLF11 in white (light blue) and brite (orange) hMADS adipocytes as well as H3K27ac profiles in hMADS adipocytes
transduced with shScramble (dark gray) or shKLF11 (light gray) from the DIO2 locus. The arrow indicates a putative KLF11-activated
binding site. (G) Correlation between the log2 fold change in KLF11 signal and H3K27ac signal in brite versus white hMADS adipocytes at
945 KLF11-activated binding sites within 100 kb of annotated RefSeq genes. r indicates Pearson’s correlation coefficient, and the red line
shows the linear regression between plotted values. (H) Plot illustrating the mean percentage change in KLF11 signal in brite compared
with white hMADS adipocytes at KLF11-activated binding sites within 100 kb of the top brite-selective (black) and white-selective (gray)
genes. Error bars represent the 95% confidence interval around the mean. (**) P-value < 0.005, two-tailed Student’s test.
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two transcription factors (Supplemental Fig. S11C). In
line with this, KLF11 knockdown reduces MED1 occu-
pancy at a subset of shared PPARg/KLF11-binding sites
within brite-selective PPARg superenhancers (Supplemen-
tal Fig. S11D), indicating that KLF11 affects the activity
of at least a subset of PPARg constituents within brite-
selective PPARg superenhancers.
To identify the functionally most important KLF11-
binding sites, we performed H3K27ac ChIP-seq in
hMADS adipocytes with or without KLF11 knockdown
and evaluated the changes in H3K27ac signal upon KLF11
knockdown at all identified KLF11-binding sites. This
allowed us to define subsets of KLF11-binding sites that
either lose (1179 sites), gain (489 sites), or have unchanged
(1076 sites) H3K27ac levels in response to KLF11 knock-
down (Supplemental Fig. S12A); i.e., sites representing
putative KLF11-activated, KLF11-repressed, and unaf-
fected sites, respectively. Interestingly, the percentage of
distal KLF11-binding sites affected by KLF11 knockdown
is significantly higher than the percentage of promoter-
proximal sites affected, suggesting that KLF11 has a prom-
inent effect on distal regions despite these being weaker
binding sites (Supplemental Fig. S12B).
We next examined how these responsive KLF11-bind-
ing sites are related to brite- and white-selective gene
programs. Interestingly, we found that the fraction of
brite-selective genes associated with putative KLF11-
activated binding sites is significantly higher than the
fraction of white-selective and constitutively expressed
genes (Fig. 6D). Furthermore, putative KLF11-activated
binding sites are enriched in the vicinity of brite-selective
genes compared with KLF11-repressed and unaffected
binding sites and are even more enriched near brite-
selective genes that are repressed by KLF11 knockdown
(Fig. 6E). In contrast, such sites are not enriched near
genes that are induced by KLF11 knockdown or near
white-selective genes (Supplemental Fig. S12C). These
results demonstrate that KLF11-activated sites are
mainly linked to brite-selective genes (see Fig. 6F; Sup-
plemental Fig. S12D for examples). Importantly, there is
a positive correlation between changes in KLF11 signal
and H3K27ac signal during browning at KLF11-activated
sites (Fig. 6G), with a specific gain of KLF11 and H3K27ac
near brite-selective compared with white-selective genes
(Fig. 6H; Supplemental Fig. S12E). Cumulatively, these
results indicate that KLF11 functions as a specific and
direct transcriptional activator of a large subset of brite-
selective genes.
In summary, we present a model (Fig. 7) for rosiglita-
zone-mediated browning of human adipocytes and show
the requirement for KLF11 in this process. In this model,
rosiglitazone stimulation of mature human adipocytes
triggers reprogramming of PPARg binding, leading to the
formation of brite-selective PPARg superenhancers, which
play an important role in activating the brite-selective
gene program. This includes genes encoding browning
transcription factors such as KLF11, which act in a co-
operativemanner with PPARg to ensure full induction and
maintenance of the brite adipocyte gene program indepen-
dently of rosiglitazone.
Discussion
In this study, we used for the first time a genome-wide
approach to characterize the transcriptional reprogramm-
ing events associated with the formation of functional
human brown-like adipocytes. Using rosiglitazone as
a browning stimulus, we show that comprehensive tran-
scriptional changes occur during the browning process to
establish a stable brite adipocyte gene program that, once
established, can bemaintained independently of rosiglita-
zone. Thus, it appears that the prolonged rosiglitazone
stimulus induces an alternatively committed differenti-
ation state in hMADS cells, where the adipocytes remain
brite even when the stimulus has been withdrawn. This
indicates that additional ‘‘stabilizing’’ browning factors
are induced by rosiglitazone and are required for mainte-
nance of browning.
Interestingly, rosiglitazone is also used in the differen-
tiation cocktail from day 3 to day 9 of hMADS differen-
tiation, at which point browning is not induced. It is
unclear why only mature white adipocytes are able to
undergo browning in response to rosiglitazone, but it is
likely that activation of the browning genes requires factors
that are not expressed until late in the differentiation of
white adipocytes.
Despite considerable changes in gene expression during
browning, the genome-wide changes in DHS are modest.
Figure 7. Model for rosiglitazone-induced browning and the role of KLF11 in this process. Rosiglitazone stimulation of mature human
adipocytes leads to reprogramming of PPARg binding, resulting in the formation of brite-selective PPARg superenhancers. These events
stimulate the expression of brite-selective genes, including the transcriptional regulator KLF11. Once induced, KLF11 acts in
a cooperative manner with PPARg and other browning factors to ensure full induction and maintenance of the brite adipocyte gene
program independently of rosiglitazone.
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This is in sharp contrast to the dramatic changes in
chromatin structure (Siersbæk et al. 2011; Waki et al.
2011) and epigenomic marks (Mikkelsen et al. 2010;
Steger et al. 2010) during 3T3-L1 adipocyte differentiation
and indicates that transcriptional changes during brown-
ing of hMADS cells occur without major global changes
in the chromatin landscape. Instead, our results indicate
that browning relies on changes of the activity of a small
subset of enhancers, possibly combined with modest
changes in the activity of additional enhancers.
The fact that browning is induced by rosiglitazone
indicated that PPARg could be a major driver of the
genomic reprogramming during browning, and we
therefore profiled PPARg in white and brite hMADS
adipocytes. We showed that only a small fraction of
PPARg-binding sites differs dramatically in PPARg occu-
pancy, indicating that PPARg acts in a site-selective
manner and that the majority of PPARg functions are
common between white and brite adipocytes. Similarly,
PPARg binding in in vitro differentiated primary adipo-
cytes obtained from different mouse white and brown
adipose depots differs only at a subset of sites (Siersbæk
et al. 2012). Importantly, and consistent with a central
role of PPARg in genomic reprogramming, we show that
reprogrammed brite-selective PPARg-binding sites corre-
spond to sites that gain enhancer activity during brown-
ing, and these sites are enriched in the vicinity of
brite-selective genes.
Interestingly, reprogramming of PPARg binding during
browning leads to the formation of brite-selective super-
enhancers (i.e., clusters of individual enhancers) recently
shown to be key drivers of gene programs that define cell
identify (Loven et al. 2013; Whyte et al. 2013). It appears
that reprogramming of PPARg binding at single constit-
uent enhancers plays a major role in redefining PPARg
superenhancers during browning. Importantly, we show
that brite-selective PPARg superenhancers are much
more enriched near brite-selective genes than regular
brite-selective PPARg enhancers. Furthermore, brite-
selective genes associated with brite-selective superen-
hancers are more dramatically induced during browning
than genes that do not have brite-selective superen-
hancers nearby. This clearly indicates the importance of
superenhancers in defining gene programs characteristic
of different adipocyte subtypes. The brite-selective super-
enhancers are enriched near genes encoding important
metabolic regulators involved in fatty acid degradation
and b-oxidation.
Since superenhancers have been reported to be associ-
ated with genes encoding lineage-determining transcrip-
tional regulators (Whyte et al. 2013), we examined the list
of genes associated with brite-selective PPARg super-
enhancers. Interestingly, both factors that were chosen
for analysis, KLF11 and FHL1, were found to be required
for browning, demonstrating that association with super-
enhancers can be used as a discovery tool to identify
novel transcriptional regulators of browning of adipo-
cytes. Here we selected KLF11, which is a member of
the SP1/KLF family of transcription factors, for further
analyses. KLFs constitute an interesting family of tran-
scription factors involved in the regulation of diverse
metabolic networks (Neve et al. 2005; Lomberk et al.
2013; Zhang et al. 2013). Several KLF family members,
including KLF2, KLF3, KLF4, KLF5, KLF6, KLF7, KLF9,
and KLF15, have been implicated in different stages of
adipogenesis (Wu and Wang 2013), but a role of KLF11 in
adipogenesis has not been described. KLF11 has been
shown to activate UCP1 expression in mouse bone
marrow-derived stem cells (Yamamoto et al. 2010); how-
ever, the impact of KLF11 on browning of adipocytes
remains unknown.
Our results identifyKLF11 as a novel PPARg target gene
in human adipocytes, presumably activated through the
nearby PPARg superenhancer. Importantly, we show by
loss of function and gain of function that KLF11 is
a selective global activator of the brite adipocyte gene
program in human adipocytes. To our knowledge, this
places KLF11 as the first PPARg-induced sequence-specific
transcription factor involved in browning. Thus, KLF11
acts as a direct molecular link between the acute rosiglita-
zone-induced gene program and stabilization of the brite
adipocyte phenotype. Cofactors that may contribute to
this link include PGC-1a, which is a PPARg target gene in
primary cultures of white and brown adipocytes (Hondares
et al. 2006), and PRDM16, which has been shown to be
activated by PPARg through increased stability (Ohno
et al. 2012). Interestingly, our data show that KLF11 can
be further induced by cooling and b-adrenergic stimulation
of brite hMADS adipocytes, suggesting that KLF11 might
be involved in mediating alternative thermogenic stimuli
in addition to rosiglitazone-induced browning. In support
of this notion, examination of microarray data from mice
subjected to cold for 10 d (Rosell et al. 2014) revealed that
KLF11 expression is induced in subcutaneous WATas part
of the cold response involving thermogenic and oxidative
genes. In line with what has previously been shown (Elabd
et al. 2009; Jespersen et al. 2013), neither b-adrenergic
stimulation nor cooling of white hMADS adipocytes is
capable of inducing browning, suggesting that additional
activation stimuli are needed for induction of a thermo-
genic response in human white adipocytes.
Browning of human adipose tissue in response to cold
has been shown to contribute significantly to human
metabolism (Ouellet et al. 2012; Yoneshiro et al. 2013),
and it is likely that rosiglitazone-induced browning of
human adipose tissue could have a similar effect (Bogacka
et al. 2005). Interestingly, our results show that KLF11
expression is induced by rosiglitazone in abdominal sub-
cutaneous adipose tissue of human T2D subjects and that
this is paralleled by an induction of UCP1 to detectable
levels in eight out of 18 subjects. Thus, in addition to the
weight gain experienced in subjects treated with rosiglita-
zone in this cohort (Tan et al. 2005), our data indicate that
at least a subset of these patients displayed modest
browning of their subcutaneous adipose tissue in re-
sponse to rosiglitazone.
Genome-wide profiling of KLF11 demonstrates that
KLF11 is primarily associated with promoter-proximal
regions, which is in line with results for another member
of the SP1/KLF family, KLF1 (Pilon et al. 2011). Since
KLF11 regulates browning of human adipocytes
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KLF11 has been reported to have both Sin3-HDAC-
dependent and HP1-HMT-dependent repressor functions
as well as p300-induced activation properties (Zhang et al.
2001; Fernandez-Zapico et al. 2009; Lomberk et al. 2012;
Seo et al. 2012), we grouped the KLF11-binding sites into
putative KLF11-activated sites (loss of H3K27ac in response
to KLF11 knockdown) and putative KLF11-repressed sites
(gain of H3K27ac in response to KLF11 knockdown). Our
results demonstrate that putative KLF11-activated binding
sites are highly enriched in the vicinity of brite-selective
genes, in particular putative KLF11-activated brite-selective
genes. A similar enrichment of KLF11-repressed sites was
not observed for genes activated by loss of KLF11. This
indicates that, in terms of the browning process, KLF11 acts
primarily as a direct activator of the brite gene program.
In conclusion, we show for the first time that rosiglita-
zone-induced browning of human adipocytes is associated
with comprehensive changes in gene expression driven in
part by brite-selective PPARg superenhancers. Further-
more, we identify KLF11 as a novel browning factor and
a direct PPARg target gene that is required for rosiglita-
zone-induced browning of human adipocytes. Thus, KLF11
constitutes a novel molecular link between the rosiglita-
zone-induced gene expression and the activation and
maintenance of the brite-selective gene program. We
propose that activation of KLF11 and other browning
factors cooperate with PPARg to establish a ‘‘stable’’
brite phenotype independent of continued administra-
tion of rosiglitazone. Future studies should investigate
the molecular cross-talk between PPARg and such brown-
ing factors.
Materials and methods
hMADS cell culturing and differentiation
hMADS-3 cells (Rodriguez et al. 2005; Zaragosi et al. 2007) were
cultured and differentiated into mature adipocytes as described in
the Supplemental Material. From day 13 to day 16 of differenti-
ation, hMADS adipocytes were treated with rosiglitazone to form
brite adipocytes or with DMSO to maintain white adipocytes.
From day 16 forward, the differentiation medium of both white
and brite adipocytes was depleted for rosiglitazone. GW9662
(Sigma) at 0.5 mM and isoproterenol (Sigma) at 1 mMwere applied
to the cell cultures as indicated.
Oil-red-O staining and glycerol-3-phosphate dehydrogenase
analysis
Oil-red-O staining was performed as previously described
(Helledie et al. 2002). Spectrophotometric analysis was used
for quantification by measuring optical density at 500 nm.
Glycerol-3-phosphate dehydrogenase activity measurements
were performed as previously described (Negrel et al. 1978).
RNA extraction, cDNA synthesis, and quantitative real-time PCR
RNA extraction, cDNA synthesis, and quantitative real-time
PCR were performed as previously described (Nielsen et al.
2006). Data were normalized to TBP unless stated otherwise.
Sequences of real-time PCR primers will be provided on request.
Two-tailed Student’s t-test was used to determine significance.
Western blotting and ECL detection
Whole-cell extracts were prepared in SDS-containing buffer and
subjected to Western blotting as previously described (Nielsen
et al. 2006). The following antibodies were used: anti-PPARg
(E-8; sc-7273, Santa Cruz Biotechnology), anti-KLF11 (10D8;
H00008462-M03, Novus Biologicals), anti-FHL1 (10991-1-AP,
Proteintech), anti-UCP1 (ab10983, Abcam), anti-Omni-probe
(D8; sc-7270, Santa-Cruz Biotechnology), anti-rabbit IgG (P0399,
DAKO), and anti-mouse IgG (P0447, DAKO). Anti-SP1 (sc-17824,
Santa-Cruz Biotechnology) or anti-TFIIB (sc-225, Santa Cruz Bio-
technology) was included as a loading control. Densitometry was
used to quantify protein expression, and a two-tailed Student’s
t-test was used to determine significance.
Lentiviral production and transduction of hMADS cells
For knockdown of PPARg (Nielsen et al. 2008), KLF11, FHL1, and
ZNF323 shRNA oligos targeting these factors were cloned into
pSicoR PGK puro vectors (Addgene), and lentiviral particles were
produced in human embryonic kidney (HEK) 293T cells as de-
scribed (Ventura et al. 2004). As a control, a shRNA nontargeting
oligo (scramble) was used. Sequences of shRNA oligos will be
provided on request. Mature hMADS adipocytes (day 10 after
induction of differentiation) were incubated for 24 h with lenti-
viral medium containing 6 mg/mL polybrene (Sigma) before the
mediumwas changed to normal differentiationmedium. shKLF11
construct #1 was used for RNA-seq experiments.
Adenoviral overexpression
The generation of the (His6-Xpress) KLF11 and control adenovi-
ral vectors (Ad5CMV) was described in Lomberk et al. (2012).
Rosiglitazone-treated hMADS adipocytes at day 15 were trans-
duced for 6 h with ;8 3 109 infectious units of adenoviral
particles per milliliter and 1 mg/mL poly-L-lysine in DMEM
(Sigma). After the initial incubation, the mediumwas changed to
normal differentiation medium without rosiglitazone, and cells
were harvested 18 h later.
b-Oxidation
Determination of b-oxidation capacity in day 16 hMADS adipo-
cytes transduced with lentivirus as described above was per-
formed essentially as previously described (Berge et al. 2003).
Mitochondrial respiration analyses
For mitochondrial respiration analysis, hMADS cells were
seeded in 24 multiwell plates (Seahorse) and differentiated and/
or transduced with lentivirus as previously described. OCR in
hMADS adipocytes at day 16 or 19 was determined using an
XF24 extracellular flux analyzer (Seahorse Bioscience). We added
1.2 mM oligomycin, 1 mM FCCP, 1 mM rotenone, and 1 mM
antimycin A to the cells as indicated.
Coimmunoprecipitation
Nucleus extraction and coimmunoprecipitation were performed
essentially as described (Siersbaek et al. 2014). In brief, nuclei
were isolated from rosiglitazone-treated hMADS adipocytes
transduced with AdEV or His-tagged AdKLF11 as described
above. Cleared nuclear extract was subjected to coimmunopre-
cipitation overnight at 4°C using anti-Omni-probe (D8; Santa-
Cruz Biotechnology, sc-7270) conjugated to agarose beads. After
washing, the immunoprecipitates were eluted by boiling in SDS
buffer and subsequently prepared for Western blotting.
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RNA-seq
Five micrograms of total RNA from hMADS preadipocytes and
mature day 19 white and brite adipocytes was treated with
a Ribo-Zero rRNA removal kit (Epicentre) and subjected to
fragmentation and cDNA synthesis using the TruSeq RNA
sample preparation kit version 2 (Illumina).
ChIP
ChIP experiments were performed in white and brite hMADS
adipocytes at day 19 essentially as previously described
(Siersbæk et al. 2012). For cross-linking of chromatin, 0.2 mM
disuccinimidyl glutarate (DSG) (Proteochem) was applied for
45 min followed by cross-linking using 1% formaldehyde for
10 min. The antibodies used were anti-PPARg (H-100; sc-7196,
Santa Cruz Biotechnology), anti-MED1 (M-255; sc-8998, Santa
Cruz Biotechnology), anti-CBP (A-22; sc-369, Santa Cruz Bio-
technology), anti-KLF11 (10D8; H00008462-M03, Novus Biologi-
cals), and anti-H3K27ac (ab4729, Abcam).
DHS site assessment
DNase I digestion was performed in white and brite hMADS
adipocytes at day 19 on ;10 million nuclei essentially as
previously described (Siersbæk et al. 2011).
Library construction
RNA-seq, DHS-seq, and ChIP-seq libraries were constructed
according to the manufacturer’s instructions (Illumina) as de-
scribed (Nielsen and Mandrup 2014). Sequencing was performed
on our in-house Illumina platform.
Data analyses
RNA-seq data RNA reads were aligned to the human reference
genome (version hg19) using Bowtie2 (Langmead and Salzberg
2012). The number of exon reads for all RefSeq genes was counted
using Subread (Liao et al. 2013), and differential expression was
determined using DESeq2 (Love et al. 2014). Functional enrich-
ment analysis was performed with HOMER (Heinz et al. 2010)
using pathways related to metabolism from the Kyoto Encyclope-
dia of Genes and Genomes (KEGG) annotation (Kanehisa and Goto
2000; Kanehisa et al. 2014)
Alignment of ChIP-seq and DHS-seq data, peak calling,
and identification of regions with differential signal intensity Se-
quence tags were aligned to the human reference genome (hg19)
using Bowtie (Langmead et al. 2009), and ChIP-seq peaks were
called using HOMER (Heinz et al. 2010). The University of
California at Santa Cruz Genome Browser (Kent et al. 2002) was
used for visualization. The differential signal intensity in bind-
ing regions/superenhancers was determined using HOMER and
EdgeR (Robinson et al. 2010).
Accession numbers Sequencing data are available from the Gene
Expression Omnibus (GEO) under accession number GSE59703.
Human subjects
Human subcutaneous abdominal fat biopsies from a double-blind,
placebo-controlled, crossover study involving T2D subjects
treated with placebo/rosiglitazone for 90 d were used to analyze
KLF11 expression. A total of 18 subjects from whom a complete
physiological data set is available was included. Details on
subjects and procedures were as described previously (Tan et al.
2005). Significance was determined using a Wilcoxon matched
pairs signed-ranks test.
Additional information is available in the Supplemental
Material.
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